Sponsors & Partners
EUVAS2026 is made possible by the generous support of our sponsors and partners, whose contributions help bring this event to life.
We are proud to showcase these valued partners and extend our sincere thanks for their ongoing support and engagement.
Statement
It is important to note that although this meeting has received sponsorship, by means of financial support, from several organisations, including pharmaceutical companies.
Sponsors have had no involvement in the development of the scientific programme or
agenda, unless explicitly stated.
Thank you to our confirmed sponsors
Headline
CSL is a company focused on iron deficiency and nephrology and is committed to advancing the development of therapies for patients across a range of kidney diseases, with a focus on dialysis and rare diseases. CSL aims to contribute to improving the lives of patients worldwide living with severe and chronic diseases.
Silver
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach 304 million people worldwide.
Bronze
NS Pharma is a biopharmaceutical leader in delivering life-changing care to people living with complex, rare diseases. Backed by over 100 years of Nippon Shinyaku Co. development expertise, we advance revolutionary rare disease therapies that help people live healthier, happier lives. Our pipeline includes therapeutic advancements in Duchene muscular dystrophy, MPS II, EGPA and LCA1. By uniting strategic partnerships, novel scientific innovation and expansive organizational expertise, we consistently drive meaningful therapeutic progress that addresses unmet needs and supports the full patient journey. Our award-winning patient services illustrate our promise to provide dedicated partnership for the unique needs of every patient.